In the News

413 News Items found
MSK Kids neuroblastoma patient Abby Hawk
Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.
Michael Roehrl
A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.
Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.
Epithelial cells
In the Lab
New findings from researchers at the Sloan Kettering Institute provide insight into a fundamental biological process called the epithelial-mesenchymal transition.
MSK patient Jason Giani holding a Valentine's Day card
Feature
Cards are a longstanding Valentine’s tradition — and The Scarlett Fund, with help from Memorial Sloan Kettering Cancer Center employees, is using cards to make sure that patients and staff will be feeling the love for a long time to come.
hematopoietic stem and progenitor cells
VEXAS syndrome is a confounding adult-onset inflammatory disease first described in 2020, which affects 1 in 4,000 men over 50. Now, MSK researchers are shedding new light on its mechanisms and laying the groundwork for potential targeted treatments.
Sandy wearing an orange tank top and running.
Read about Sandy Freiberg, who ran a marathon to honor his brother, Evan, who is in his fifth year of cancer treatment at Memorial Sloan Kettering.
MSK thoracic surgeon Prasad Adusumilli talking to patient.
Read about the latest MSK research to make CAR T therapy effective against solid tumors.
a lab coat hangs in an MSK lab
Drs. Anna-Katerina Hadjantonakis and Robert Farese were elected to the 2026 class of the American Academy of Arts and Sciences.
Three GSK students in a classroom
Seven GSK PhD students were awarded nine competitive fellowships from prestigious external agencies such as the National Cancer Institute (NCI) and National Science Foundation (NSF).